You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Bafna Pharmaceuticals Ltd"

Bafna Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

  • 11/08/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Board Meeting Outcome for .:- Regulation 30 Read With Reg. 33 Of SEBI (Listing Obligations And Discl

  • 11/08/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Board Meeting Intimation for Board Meeting To Consider The Unaudited Results For The Quarter Ended 3

  • 04/08/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report

  • 29/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 29/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM

  • 28/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 08/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 06/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Reg. 34 (1) Annual Report.

  • 06/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended June 2022

  • 06/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Intimation Of Annual General Meeting And Book Closure Under Regulation 42 Of The Securities And Exch

  • 05/07/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Closure of Trading Window

  • 28/06/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 28/05/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Outcome of Board Meeting (AGM on July 28 2022)

  • 26/05/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th May 2022

  • 26/05/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Inter-Alia Consider And A

  • 20/05/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

  • 09/05/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 13/04/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Certificate From Practicing Company Secretary For The Half Year Ended 31St March 2022

  • 11/04/2022
  • |
  • bse

Bafna Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 07/04/2022
  • |
  • bse
.